Cervical cancer test kit Anyplex™ II

for sexually transmitted diseasesfor genotypingfor genes

Simultaneous detection and identification of 28 HPV types (19 high-risk and 9 low-risk) Anyplex™Ⅱ HPV28 Detection simultaneously detects, differentiates and quantifies 28 distinct HPV genotypes (19 high-risk and 9 low-risk) responsible for cervical cancer and/or sexually transmitted infections. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this multiplex assay performs on real-time PCR instrument and provides high sensitivity and specificity genotyping information of infected 28 HPV types in a single reaction KEY FEATURES AND BENEFITS Multiplex real-time PCR Detection and identification of 19 high-risk HPV and 9 low-risk HPV in a single reaction Automatic data analyzer Automated data interpretation and LIS interlocking with Seegene Viewer Informative assay Assistant of appropriate treatment and management for co-infection Whole process validation Whole process validation from extraction to PCR by whole process control Useful monitoring Useful tool for surveillance and infection control User-friendly workflow Convenient workflow using Seegene’s automated one platform Quantitative analysis Quantitative analysis by cyclic-CMTA UDG system Utilization of the UDG system to prevent carry-over contamination Powerful performance with unique technology Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies